Phacoemulsification in Patients With Corneal Opacities

August 13, 2021 updated by: Mahmoud F. Rateb, Assiut University

Phacoemulsification in Patients With Corneal Opacities Using Slit Illumination of the Surgical Microscope

In this retrospective case series, the feasibility of performing phacoemulsification using slit illumination in eyes with corneal opacity was assessed.

Study Overview

Status

Completed

Conditions

Detailed Description

Corneal opacity is often encountered in patients seeking senile cataract surgery in developing countries. Corneal opacity impairs the intraoperative visualization during cataract surgery which increases the risk of copmlications.

Several techniques were described to enhance the intraoperative visualization such as the use of anterior endoscopy, chandeiler retroillumination, and anterior chamber endoillumination. All these techniques require costly instrumentation.

the aim of this study was to assess the feasibility of performing phacoemulsification using slit illumination of the surgical microscope without the need of additional instruments, and report the visual outcome.

Study Type

Observational

Enrollment (Actual)

10

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with visually significant senile cataract and corneal opacities

Description

Inclusion criteria:

  • The presence of visually significant senile cataract.
  • A recent history of progressive diminution of vision within few months.
  • Stable density and size of a preexisting trachomatous corneal opacity that does not impair the pupil or lens visualization after pupillary dilatation.

Exclusion Criteria:

  • History of trauma, infectious corneal ulcers, or intraocular surgery.
  • Coexisting ocular diseases e.g. glaucoma, retinal detachment, and vitreous hemorrhage.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The rate of intra-operative complications of phacoemulsification in eyes with corneal opacities using the slit ilumination of the surgical microscope.
Time Frame: 3 months
the frequency of the intraoperative complications of phacoemulsification in eyes with corneal opacities
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual outcome of phacoemulsification in eyes with corneal opacities
Time Frame: 3 months
meaurement of the change of the distance corrected visual acuity bafoer after phacoemulsification using Snellen chart
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2015

Primary Completion (Actual)

December 30, 2017

Study Completion (Actual)

July 31, 2018

Study Registration Dates

First Submitted

August 9, 2021

First Submitted That Met QC Criteria

August 13, 2021

First Posted (Actual)

August 20, 2021

Study Record Updates

Last Update Posted (Actual)

August 20, 2021

Last Update Submitted That Met QC Criteria

August 13, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • phacoemulsification surgery

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Senile Cataract

Clinical Trials on Phacoemulsification in eyes with corneal opacities

3
Subscribe